| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.46 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.44 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.009 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 0.01 |